Saturday, March 06, 2021 6:26:27 AM
Excellent find on VIP ratna1!! ——————
Anxiety Disorders and Depression Treatment Market Size Worth USD 13.03 Billion at 2.6% CAGR; Market Leaders Such as Pfizer and Eli Lilly to Make Massive Investments to Boost R&D Capabilities: Fortune Business Insights™
https://www.globenewswire.com/news-release/2021/02/01/2167163/0/en/Anxiety-Disorders-and-Depression-Treatment-Market-Size-Worth-USD-13-03-Billion-at-2-6-CAGR-Market-Leaders-Such-as-Pfizer-and-Eli-Lilly-to-Make-Massive-Investments-to-Boost-R-D-Capa.html
Anxiety Disorders and Depression Treatment Market Size Worth USD 13.03 Billion at 2.6% CAGR; Market Leaders Such as Pfizer and Eli Lilly to Make Massive Investments to Boost R&D Capabilities: Fortune Business Insights™
https://www.globenewswire.com/news-release/2021/02/01/2167163/0/en/Anxiety-Disorders-and-Depression-Treatment-Market-Size-Worth-USD-13-03-Billion-at-2-6-CAGR-Market-Leaders-Such-as-Pfizer-and-Eli-Lilly-to-Make-Massive-Investments-to-Boost-R-D-Capa.html
Recent RLFTF News
- MindMaze Therapeutics Announces Initiation of Coverage by Baader Bank • ACCESS Newswire • 03/19/2026 06:35:00 AM
- MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics • ACCESS Newswire • 12/23/2025 06:20:00 AM
- Relief Therapeutics and NeuroX Complete Business Combination and Form MindMaze Therapeutics • ACCESS Newswire • 12/15/2025 06:20:00 AM
- Relief Therapeutics Shareholders Approve Business Combination with NeuroX • ACCESS Newswire • 11/14/2025 05:40:00 PM
- Relief Therapeutics Announces Positive Results from Pivotal Bioequivalence Study of RLF-OD032 • ACCESS Newswire • 10/29/2025 06:20:00 AM
- Micro-Cap Biotech Skyrockets on FDA Pediatric Disease Nod • AllPennyStocks.com • 05/22/2025 04:49:00 PM
